These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24511110)

  • 1. The challenge to optimize medical therapy for advanced colorectal cancer.
    Hubbard JM; Grothey A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt442. PubMed ID: 24511110
    [No Abstract]   [Full Text] [Related]  

  • 2. Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer.
    Ko SY; Blatch GL; Dass CR
    Cancer Metastasis Rev; 2014 Mar; 33(1):101-13. PubMed ID: 24338005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Triage Trials in Colorectal Cancer.
    O'Hara MH; Hamilton SR; O'Dwyer PJ
    Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Issues of molecular targeted therapies in combination with chemotherapy in metastatic colorectal cancer].
    Asayama M; Kadowaki S; Yamaguchi K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():464-71. PubMed ID: 22214005
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reception and adjuvant chemotherapy for metastatic site of colorectal cancer].
    Nakamura M
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1381-6. PubMed ID: 25577807
    [No Abstract]   [Full Text] [Related]  

  • 6. Mismatch repair deficiency predicts benefit of anti-PD-1 therapy.
    Lau E
    Lancet Oncol; 2015 Jul; 16(7):e319. PubMed ID: 26062774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy for advanced colorectal cancer].
    Munakata M; Sakata Y
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():30-6. PubMed ID: 22213927
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Sabanathan D; Eslick GD; Shannon J
    Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).
    Jin D; Fang Y; Li Z; Chen Z; Xiang J
    Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDITORIAL: Molecularly targeted treatments for colorectal cancer: advances and limitations.
    Parodi S
    Curr Cancer Drug Targets; 2012 May; 12(4):301-2. PubMed ID: 22385508
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiogenesis in Colorectal Cancer: Antibodies.
    Chan E
    Cancer J; 2016; 22(3):179-81. PubMed ID: 27341595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials.
    Pei X; Liu Y; Sun L; Zhang J; Fang Y; Liao X; Liu J; Zhang C; Yin T
    Clin Colorectal Cancer; 2016 Dec; 15(4):e149-e156. PubMed ID: 27155750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.
    Strickler JH; Wu C; Bekaii-Saab T
    Cancer Treat Rev; 2017 Nov; 60():109-119. PubMed ID: 28946014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways of Colorectal Cancer Development: Mechanisms of Action and Evolution of Main Systemic Therapy Compunds.
    Pierantoni C; Cosentino L; Ricciardiello L
    Dig Dis; 2024; 42(4):319-324. PubMed ID: 38531339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Colorectal Cancer Stem Cell.
    Medema JP
    N Engl J Med; 2017 Aug; 377(9):888-890. PubMed ID: 28854096
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade?
    Venook AP; Saltz LB
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress of targeted therapy related to K-ras mutation].
    Li ZW; Liu YQ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):59-61. PubMed ID: 22455857
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies.
    Patel GS; Ullah S; Beeke C; Hakendorf P; Padbury R; Price TJ; Karapetis CS
    Cancer Med; 2015 Oct; 4(10):1461-71. PubMed ID: 26211512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin, the new targeted therapy in colorectal cancer.
    Fuchs CS
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):186-9. PubMed ID: 24927268
    [No Abstract]   [Full Text] [Related]  

  • 20. Colorectal cancer: how emerging molecular understanding affects treatment decisions.
    Sridharan M; Hubbard JM; Grothey A
    Oncology (Williston Park); 2014 Feb; 28(2):110-8. PubMed ID: 24701697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.